Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

BTAI

BioXcel Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · BTAI

All alert types
0.07 USD 0.00 0.00%
As of Sep 4, 2026 Extended hours 1.30 +1,659.13%
Bid
1.29 × 1
Ask
1.30 × 1
0.069 Day range 0.0935
0.30 52-week range 4.17
YTD
-95.38%
1 year
-96.36%
Open
0.091
Prev close
0.0739
Mkt cap
16.98M
Vol
47.48M
Avg vol
616.96K
EPS
-2.04
P/E
0.00
Div yield
0.00%
More statistics
Low
0.069
High
0.0935
Forward P/E
-0.21
Beta
0.29
Short ratio
0.93
Inst. own
8.76%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
0.53274
200-d avg
1.28
1y target
5.00

5D chart

Chart tools
Interval
1m5m15m30m
BTAI five-day price chart0.000.250.500.751.00

Financial health

Altman Z-Score

-46.97 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2016: -85.7×FY 2017: -40.0×FY 2018: -2.9×FY 2019: -7.2×FY 2020: -12.2×FY 2021: -5.0×FY 2022: -3.6×FY 2023: -0.5×FY 2024: -0.3×FY 2025: -0.3×
FY 2016 5y median -0.5× FY 2025
P/S 30.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 1605×FY 2023: 62.3×FY 2024: 6.7×FY 2025: 30.4×
FY 2016 5y median 30.4× FY 2025
P/B -0.2×
FY 2016: -560×FY 2017: -185×FY 2018: 1.4×FY 2019: 8.8×FY 2020: 4.8×FY 2021: 2.4×FY 2022: 7.8×FY 2023: -1.5×FY 2024: -0.2×FY 2025: -0.2×
FY 2016 5y median -0.2× FY 2025
P/FCF -0.3×
FY 2016: -140×FY 2017: -82.7×FY 2018: -4.1×FY 2019: -8.5×FY 2020: -15.0×FY 2021: -6.5×FY 2022: -4.4×FY 2023: -0.6×FY 2024: -0.2×FY 2025: -0.3×
FY 2016 5y median -0.6× FY 2025
EV/EBITDA -1.9×
FY 2016: 0.0×FY 2017: -39.9×FY 2018: -0.7×FY 2019: -6.3×FY 2020: -9.6×FY 2021: -2.9×FY 2022: -3.2×FY 2023: -0.7×FY 2024: -2.0×FY 2025: -1.9×
FY 2016 5y median -2.0× FY 2025
EV/Sales 157×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 1339×FY 2023: 88.5×FY 2024: 38.9×FY 2025: 157×
FY 2016 5y median 88.5× FY 2025
FCF Yield -295.0%
FY 2016: -0.7%FY 2017: -1.2%FY 2018: -24.6%FY 2019: -11.8%FY 2020: -6.7%FY 2021: -15.4%FY 2022: -22.5%FY 2023: -180.4%FY 2024: -475.1%FY 2025: -295.0%
FY 2016 5y median -180.4% FY 2025

Profitability

Gross Margin 74.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 94.7%FY 2023: 8.7%FY 2024: 5.4%FY 2025: 74.5%
FY 2016 5y median 8.7% FY 2025
Operating Margin -7829.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -42572.0%FY 2023: -12448.0%FY 2024: -2967.6%FY 2025: -7829.8%
FY 2016 5y median -7829.8% FY 2025
Net Margin -10887.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -44201.9%FY 2023: -12974.9%FY 2024: -2630.1%FY 2025: -10887.4%
FY 2016 5y median -10887.4% FY 2025
ROE 73.2%
FY 2016: 654.3%FY 2017: 462.2%FY 2018: -49.6%FY 2019: -120.2%FY 2020: -39.8%FY 2021: -48.2%FY 2022: -215.9%FY 2023: 316.9%FY 2024: 64.0%FY 2025: 73.2%
FY 2016 5y median 64.0% FY 2025
ROIC -314.4%
FY 2016: 654.3%FY 2017: 742.6%FY 2018: -51.3%FY 2019: -120.3%FY 2020: -39.5%FY 2021: -47.9%FY 2022: -92.1%FY 2023: -367.2%FY 2024: -408.1%FY 2025: -314.4%
FY 2016 5y median -314.4% FY 2025
ROA -155.6%
FY 2016: -30285.7%FY 2017: -335.0%FY 2018: -44.2%FY 2019: -88.9%FY 2020: -37.4%FY 2021: -44.7%FY 2022: -80.5%FY 2023: -242.9%FY 2024: -155.5%FY 2025: -155.6%
FY 2016 5y median -155.5% FY 2025

Growth (YoY)

Revenue -71.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 268.0%FY 2024: 64.2%FY 2025: -71.7%
FY 2016 FY 2025
Operating Income 25.2%
FY 2016: -233.3%FY 2017: -114.0%FY 2018: -340.0%FY 2019: -68.3%FY 2020: -144.9%FY 2021: -29.9%FY 2022: -49.3%FY 2023: -7.6%FY 2024: 60.9%FY 2025: 25.2%
FY 2016 FY 2025
EPS (diluted) 75.6%
FY 2016: -221.9%FY 2017: -114.1%FY 2018: -379.8%FY 2019: -53.0%FY 2020: -87.2%FY 2021: -7.0%FY 2022: -45.9%FY 2023: -3.9%FY 2024: 76.1%FY 2025: 75.6%
FY 2016 FY 2025
Free Cash Flow 20.0%
FY 2016: -361.9%FY 2017: -69.2%FY 2018: -530.6%FY 2019: -103.3%FY 2020: -136.8%FY 2021: -23.9%FY 2022: -64.0%FY 2023: -14.4%FY 2024: 53.5%FY 2025: 20.0%
FY 2016 FY 2025

Financial Health

Current Ratio 0.8×
FY 2016: 0.0×FY 2017: 0.4×FY 2018: 9.3×FY 2019: 4.0×FY 2020: 18.3×FY 2021: 14.2×FY 2022: 6.2×FY 2023: 2.6×FY 2024: 1.7×FY 2025: 0.8×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 0.8×
FY 2016: 0.0×FY 2017: 0.4×FY 2018: 9.3×FY 2019: 4.0×FY 2020: 18.3×FY 2021: 14.2×FY 2022: 6.1×FY 2023: 2.6×FY 2024: 1.7×FY 2025: 0.8×
FY 2016 5y median 2.6× FY 2025
Debt / Equity -1.1×
FY 2016: 0.0×FY 2017: -0.4×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 1.2×FY 2023: -1.8×FY 2024: -1.1×FY 2025: -1.1×
FY 2016 5y median -1.1× FY 2025
Net Debt / EBITDA -1.5×
FY 2016: 0.0×FY 2017: 0.1×FY 2018: 2.2×FY 2019: 1.0×FY 2020: 2.6×FY 2021: 2.2×FY 2022: 0.6×FY 2023: -0.2×FY 2024: -1.7×FY 2025: -1.5×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -3.0×
FY 2016: 0.0×FY 2017: -2269×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -3048×FY 2021: -2673×FY 2022: -19.4×FY 2023: -12.9×FY 2024: -4.4×FY 2025: -3.0×
FY 2016 5y median -12.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31